PMA device
DiamondTemp Ablation System
Medtronic, Inc. · Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation (OAE, Class III) · First FDA decision Jan 28, 2021, newest Oct 10, 2025Atrial fibrillation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
PMA pathway
Device trials
7
Naming "DiamondTemp"
MAUDE reports
0
Brand "DiamondTemp", since 2015
PubMed studies
23
Mentioning "DiamondTemp"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing DiamondTemp Ablation System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 5 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Left Atrial Appendage Closure (LAAC)National determinationOn the books20.34Updated Nov 4, 2026
- Percutaneous Left Atrial Appendage (LAA) Closure TherapyNational analysisReview closedCAG-00445NUpdated Sep 21, 2026
- Cardiac Catheterization Performed In Other Than A Hospital SettingNational analysisReview closedCAG-00166NUpdated Sep 16, 2026
- Cardiac Catheterization Performed in Other than a Hospital Setting - RETIREDNational determinationOn the books20.25Updated Dec 3, 2024
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33959CGS Administrators, LLCUpdated Oct 30, 2026
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33557Wellpoint FederalUpdated Jul 14, 2026
- Percutaneous minimally invasive fusion/stabilization of the sacroiliac joint for the treatment of back painLocal determinationIn effectL36000WPS Insurance CorporationUpdated May 21, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "DiamondTemp", any status and sponsor, newest update first.
- DiamondTemp Global RegistryActive, not recruiting
Medtronic Cardiac Ablation SolutionsPublic (MDT)
NCT04735016 · 545 participants (planned) · Start Apr 22, 2021 · Primary completion Dec 31, 2026
Device: DiamondTemp™ Ablation System · For: Arrhythmia
Sites: Birtinya, Australia; Murdoch, Australia; Jette, Belgium · 21 sites in all
- DIAMOND AF Post-Approval StudyTerminated
Medtronic Cardiac Ablation SolutionsPublic (MDT)
NCT05230524 · 84 participants · Start Feb 28, 2022 · Primary completion Dec 17, 2025
Device: DiamondTemp™ Ablation System · For: Paroxysmal Atrial Fibrillation
Sites: Winter Park, Florida; Pau, France; Saint-Pierre, France · 5 sites in all
University Hospitals Coventry and Warwickshire NHS TrustAcademic, hospital or other
NCT06028919 · 61 participants · Start Sep 26, 2022 · Primary completion Nov 21, 2025
Device: Temperature controlled DiamondTemp (DT) ablation catheter; Tacticath/Tactiflex (TF) ablation catheter · For: Ventricular Tachycardia
Sites: Coventry, United Kingdom; Brighton, United Kingdom
4 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "DiamondTemp", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code OAE
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "DiamondTemp"[tiab]. The summary above synthesizes these.
- Revival of the Forgotten.
Rottner L, Moser F, Moser J, et al. · Int Heart J · 2022
- A Novel Temperature-Controlled Radiofrequency Catheter Ablation System Used to Treat Patients With Paroxysmal Atrial Fibrillation.
Kautzner J, Albenque JP, Natale A, et al. · JACC Clin Electrophysiol · 2021Multicenter Study, Randomized Controlled Trial
- High-Power Short-Duration Temperature-Controlled Radiofrequency Ablation for the Treatment of Outflow Tract Ventricular Arrhythmias.
Leftheriotis D, Flevari P, Papathanasiou KA, et al. · J Cardiovasc Electrophysiol · 2025Research Support, Non-U.S. Gov't
- Compatibility of a novel temperature-controlled, irrigated radiofrequency catheter with ultra-high-density mapping.
Rodriguez Muñoz D, Marco Del Castillo Á, Ramos Jimenez J, et al. · J Arrhythm · 2023
- Efficacy and safety of novel temperature-controlled radiofrequency ablation system during pulmonary vein isolation in patients with paroxysmal atrial fibrillation: TRAC-AF study.
Starek Z, Lehar F, Jez J, et al. · J Interv Card Electrophysiol · 2022Clinical Trial, Multicenter Study
- Temperature-Controlled Radiofrequency Ablation for Pulmonary Vein Isolation in Patients With Atrial Fibrillation.
Iwasawa J, Koruth JS, Petru J, et al. · J Am Coll Cardiol · 2017Clinical Trial
- Editorial to "The effect of ablation settings on lesion characteristics with DiamondTemp ablation system: An ex vivo experiment".
Futyma P, Chen S · J Arrhythm · 2024Editorial
- Characterizing lesion morphology of a novel diamond-tip temperature-controlled irrigated radiofrequency ablation catheter.
Dhanjal TS, Schmidt MM, Getman MK, et al. · J Interv Card Electrophysiol · 2024
- Efficacy and safety of a novel temperature-controlled catheter for cavotricuspid isthmus ablation.
Sano M, Yamaji H, Higashiya S, et al. · J Cardiovasc Electrophysiol · 2024Comparative Study
- Compatibility assessment of a temperature-controlled radiofrequency catheter with a novel electroanatomical mapping system.
Pannone L, Eltsov I, Ramak R, et al. · Front Cardiovasc Med · 2023
- First clinical experience using the DiamondTemp catheter and a novel omnipolar high-resolution mapping system for atrial fibrillation ablation.
Sohns C, Fink T, Bergau L, et al. · Cardiol J · 2023
- Universal Method of Compatibility Assessment for Novel Ablation Technologies With Different 3D Navigation Systems.
Pannone L, Eltsov I, Ramak R, et al. · Front Cardiovasc Med · 2022
Other devices of this type
Also filed under product code OAE.
- Arctic Front Advance and Arctic Front Advance ProMedtronic Cryocath, LP · PMA 2024
- Arctic Front Cardiac Cryoablation Catheter SystemMedtronic Cryocath, LP · PMA 2024
- TactiCath Contact Force Ablation Catheter, Sensor EnabledSt Jude Medical · PMA 2023
- HeartLight Catheter, HeartLight X3 Console V2Cardiofocus, Inc. · PMA 2023
- TactiFlex Sensor Enabled Ablation CatheterAbbott Medical · PMA 2026
- TactiCath Quartz Contact Force Ablation CatheterSt Jude Medical · PMA 2021
- QDOT MICRO SystemBiosense Webster, Inc. · PMA 2025
- POLARx/POLARx FIT Cryoablation CathetersBoston Scientific Corporation · PMA 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.